The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir

2016

Background: There are limited options for chronic hepatitis B (CHB) patients who have poor responses to adefovir (ADV).

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

39

References

0

Citations